Cargando…

Best serum biomarker combination for ovarian cancer classification

BACKGROUND: Screening test using CA-125 is the most common test for detecting ovarian cancer. However, the level of CA-125 is diverse by variable condition other than ovarian cancer. It has led to misdiagnosis of ovarian cancer. METHODS: In this paper, we explore the 16 serum biomarker for finding a...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Hye-Jeong, Yang, Eun-Suk, Kim, Jong-Dae, Park, Chan-Young, Kyung, Min-Sun, Kim, Yu-Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219009/
https://www.ncbi.nlm.nih.gov/pubmed/30396341
http://dx.doi.org/10.1186/s12938-018-0581-6
_version_ 1783368564241072128
author Song, Hye-Jeong
Yang, Eun-Suk
Kim, Jong-Dae
Park, Chan-Young
Kyung, Min-Sun
Kim, Yu-Seop
author_facet Song, Hye-Jeong
Yang, Eun-Suk
Kim, Jong-Dae
Park, Chan-Young
Kyung, Min-Sun
Kim, Yu-Seop
author_sort Song, Hye-Jeong
collection PubMed
description BACKGROUND: Screening test using CA-125 is the most common test for detecting ovarian cancer. However, the level of CA-125 is diverse by variable condition other than ovarian cancer. It has led to misdiagnosis of ovarian cancer. METHODS: In this paper, we explore the 16 serum biomarker for finding alternative biomarker combination to reduce misdiagnosis. For experiment, we use the serum samples that contain 101 cancer and 92 healthy samples. We perform two major tasks: Marker selection and Classification. For optimal marker selection, we use genetic algorithm, random forest, T-test and logistic regression. For classification, we compare linear discriminative analysis, K-nearest neighbor and logistic regression. RESULTS: The final results show that the logistic regression gives high performance for both tasks, and HE4-ELISA, PDGF-AA, Prolactin, TTR is the best biomarker combination for detecting ovarian cancer. CONCLUSIONS: We find the combination which contains TTR and Prolactin gives high performance for cancer detection. Early detection of ovarian cancer can reduce high mortality rates. Finding a combination of multiple biomarkers for diagnostic tests with high sensitivity and specificity is very important.
format Online
Article
Text
id pubmed-6219009
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62190092018-11-08 Best serum biomarker combination for ovarian cancer classification Song, Hye-Jeong Yang, Eun-Suk Kim, Jong-Dae Park, Chan-Young Kyung, Min-Sun Kim, Yu-Seop Biomed Eng Online Research BACKGROUND: Screening test using CA-125 is the most common test for detecting ovarian cancer. However, the level of CA-125 is diverse by variable condition other than ovarian cancer. It has led to misdiagnosis of ovarian cancer. METHODS: In this paper, we explore the 16 serum biomarker for finding alternative biomarker combination to reduce misdiagnosis. For experiment, we use the serum samples that contain 101 cancer and 92 healthy samples. We perform two major tasks: Marker selection and Classification. For optimal marker selection, we use genetic algorithm, random forest, T-test and logistic regression. For classification, we compare linear discriminative analysis, K-nearest neighbor and logistic regression. RESULTS: The final results show that the logistic regression gives high performance for both tasks, and HE4-ELISA, PDGF-AA, Prolactin, TTR is the best biomarker combination for detecting ovarian cancer. CONCLUSIONS: We find the combination which contains TTR and Prolactin gives high performance for cancer detection. Early detection of ovarian cancer can reduce high mortality rates. Finding a combination of multiple biomarkers for diagnostic tests with high sensitivity and specificity is very important. BioMed Central 2018-11-06 /pmc/articles/PMC6219009/ /pubmed/30396341 http://dx.doi.org/10.1186/s12938-018-0581-6 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Song, Hye-Jeong
Yang, Eun-Suk
Kim, Jong-Dae
Park, Chan-Young
Kyung, Min-Sun
Kim, Yu-Seop
Best serum biomarker combination for ovarian cancer classification
title Best serum biomarker combination for ovarian cancer classification
title_full Best serum biomarker combination for ovarian cancer classification
title_fullStr Best serum biomarker combination for ovarian cancer classification
title_full_unstemmed Best serum biomarker combination for ovarian cancer classification
title_short Best serum biomarker combination for ovarian cancer classification
title_sort best serum biomarker combination for ovarian cancer classification
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219009/
https://www.ncbi.nlm.nih.gov/pubmed/30396341
http://dx.doi.org/10.1186/s12938-018-0581-6
work_keys_str_mv AT songhyejeong bestserumbiomarkercombinationforovariancancerclassification
AT yangeunsuk bestserumbiomarkercombinationforovariancancerclassification
AT kimjongdae bestserumbiomarkercombinationforovariancancerclassification
AT parkchanyoung bestserumbiomarkercombinationforovariancancerclassification
AT kyungminsun bestserumbiomarkercombinationforovariancancerclassification
AT kimyuseop bestserumbiomarkercombinationforovariancancerclassification